Drugs with this side effect
- 1,25(OH)2D3
- 2-hydroxysuccinaldehyde: 6%
- 4-AP: 9%
- 5-ASA: postmarketing, 1% - 5%
- 5-FU
- 5-aza-2'-deoxycytidine: 13.6% - 27.7%
- 5-azacytidine: common, 0% - 10.9%
- 8-MOP
- AMD3100: common, 0% - 7%
- Anidulafungin: 9.6% - 15.3%
- Azarga: uncommon
- BCNU: 2% - 1-10%
- BPTI
- Bivalirudin: 1.4% - 6.57%
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- CGP 19835A: common
- Cancidas: 0% - 2.2%
- Cantril
- Carfilzomib: 0% - 17.9%
- Enfuvirtide
- Estrofem
- FK463: 3.96% - 8.29%
- Forteo: 4.3%
- Goserelin: 1% - 16%
- Histrelin
- ICI 182,780: 6.9% - 8.5%
- Implanon: postmarketing
- K779: 1% - 41%
- Kaluril
- L-Dmp: 1.3%
- LY146032: postmarketing, common, 4.5% - 9.2%
- Leuprorelin: 5% - 7%
- Lisinopril: 0.3% - 2.4%
- Lovaza
- MDV3100: 0% - 8.8%
- MK-462
- Madopar
- Meropenem anhydrous
- Mersyndol
- Metrodin
- N-methylscopolamine
- Nafarelin
- Octreotide: 0.5-2%
- Oestrogen: 0.484% - 9.8%
- PCI-32765
- Photofrin: 1.01% - 14%
- Photofrin II: common
- Promacta
- Refludan
- Revasc
- SOM230: 3.66% - 13.8%
- SU5416: 16%
- Signifor: 3.66% - 13.8%
- SonoVue
- Stalevo 50
- Supremon: 4.76%
- TMC435: 14%
- TR-700
- Triptorelin: 0.8% - 5%
- Trisequens
- UDCA: 1.9% - 1.94%
- VACV: 0% - 21%
- Vallergan
- Vancocine
- Zyprexa Relprevv
- abacavir: 6.77% - 9.33%
- abiraterone: 0% - 0.2%
- acamprosate: 6% - 9%
- acebutolol: 1% - 6%
- acetaminophen: 7.46%
- acitretin: postmarketing, 1-10%
- acyclovir
- afatinib: 0% - 15%
- agomelatine
- aliskiren
- allopurinol: postmarketing
- almotriptan: rare
- alpha-methyl-p-tyrosine
- alprazolam: frequent, 1.3% - 29.4%
- amantadine: uncommon, common
- ambrisentan: 1.49% - 2.31%
- amiloride
- aminophylline
- amiodarone
- amisulpride: common, 10% - 11%
- amitriptyline
- amlodipine
- amlodipine besylate
- amoxapine
- amoxicillin: postmarketing
- amphetamine
- amphotericin B: 14.2% - 22.1%
- anagrelide: 1-5%
- anastrozole: 5.93% - 9.99%
- anthracycline: 0% - 14%
- apomorphine
- apraclonidine
- aprepitant: 2.1% - 5.6%
- aripiprazole: 4% - 24%
- arsenic
- arsenic trioxide
- asenapine: 1.9% - 16%
- atazanavir: uncommon, 1% - 5%
- atenolol
- atomoxetine: common, 13% - 16%
- atorvastatin: 3%
- atosiban
- atovaquone: 10% - 19%
- atropine
- avanafil
- azithromycin
- aztreonam
- baclofen: common, 0% - 10%
- balsalazide: 2% - 2.4%
- benazepril
- benazeprilat
- bendamustine: 0%
- benzphetamine
- bepridil: 2.65%
- betaxolol: postmarketing, 1.2% - 8.2%
- bexarotene: common, 4.76% - 11.3%
- bezafibrate: 1.1%
- bicalutamide: 5%
- bimatoprost
- bisoprolol: 1.5% - 2.5%
- boceprevir: very common, 20% - 34%
- bortezomib: 0% - 27.2%
- bosentan
- brimonidine: very rare
- brinzolamide
- bromocriptine: postmarketing, rare
- budesonide: 2.35% - 11%
- bupivacaine
- buprenorphine: 3% - 28.2%
- bupropion: 1% - 45%
- buspirone: 3%
- busulfan: 80% - 84%
- butorphanol: infrequent, 11%
- cabergoline: 0.866% - 17.3%
- candesartan cilexetil
- capecitabine: 1% - 10%
- captopril
- carbamazepine: postmarketing
- carbidopa: 1% - 1.2%
- carbinoxamine
- carisoprodol: postmarketing
- carnitine: 3% - 6%
- carteolol
- carvedilol: 1% - 2%
- cefaclor: rare
- cefdinir
- cefditoren
- cefpodoxime
- cefprozil
- ceftobiprole
- celecoxib: 1.3% - 2.9%
- celiprolol
- cephem
- cerivastatin
- cetirizine: postmarketing, 1.17%
- cevimeline: 2.4%
- chloroquine
- chlorpheniramine
- chlorpromazine
- choline theophyllinate
- cidofovir
- cilazapril
- cilostazol
- cinoxacin
- ciprofloxacin: postmarketing
- citalopram: 1% - 18.8%
- cladribine: common, 3% - 7%
- clarithromycin: postmarketing
- clemastine
- clobazam: 1.8% - 7%
- clomiphene citrate: 1.9%
- clomipramine: common, 11% - 25%
- clonazepam
- clonidine: 2% - 6%
- clopidogrel
- clorazepate
- clozapine: 2% - 33%
- cobicistat: common
- codeine
- colestimide: uncommon
- colestipol
- conivaptan: 3.3%
- conjugated estrogens
- copolymer 1
- cortisol
- cyclizine
- cyclobenzaprine: 0%
- cyproheptadine
- cytarabine: 13.6% - 25%
- dabrafenib: 0% - 18%
- dalteparin
- dantrolene
- dapsone
- darifenacin: uncommon
- darunavir: 0.806% - 3.05%
- dasatinib
- deferasirox
- degarelix
- delamanid
- delavirdine
- demethyl
- deprenyl: postmarketing, 1% - 12%
- desipramine
- desloratadine
- desmopressin: 0.96%
- desvenlafaxine: 9% - 15%
- dexamethasone
- dexamethasone sodium phosphate
- dexrazoxane
- dextrorphan
- diazepam
- diazoxide
- diclofenac: very rare
- dicyclomine: postmarketing
- diethylpropion
- diflunisal
- dihydroergotamine: infrequent
- diltiazem: 0.952% - 0.99%
- dimenhydrinate
- diphenhydramine
- disopyramide
- docetaxel: 0%
- dofetilide: 4%
- dolutegravir: 1% - 3%
- domperidone
- donepezil: 2% - 14%
- dorzolamide
- dothiepin
- doxazosin: 1% - 2.2%
- doxepin: rare
- doxercalciferol
- doxorubicin: common
- doxycycline: 1.5% - 3.4%
- doxycycline hyclate
- duloxetine: 5% - 16%
- dyphylline
- efavirenz: common, 0% - 7%
- eletriptan: infrequent
- eltrombopag
- elvitegravir: uncommon
- emtricitabine: postmarketing, common, 7%
- entacapone: common, 6.3%
- entecavir: uncommon, common, 0% - 2%
- ephedrine
- epinephrine
- eplerenone: uncommon
- eprosartan
- eribulin
- erlotinib: 12%
- ertapenem: 3% - 4.1%
- eslicarbazepine
- eslicarbazepine acetate
- esomeprazole magnesium
- estradiol: postmarketing, 0% - 6.38%
- estramustine: 0% - 3%
- estramustine phosphate
- ethotoin
- etodolac
- etoricoxib
- etravirine
- everolimus: uncommon, common, very common, 0% - 26.9%
- exemestane: very common, 3.3% - 11-20%
- exenatide: 0.448% - 2.76%
- ezetimibe
- famciclovir: 1.2% - 1.84%
- famotidine
- febuxostat
- felbamate: 4% - 17.5%
- felodipine
- fenofibrate: 1.05%
- fenofibric acid
- fenoldopam
- fenoprofen
- fentanyl: very rare, postmarketing, common, 0% - 10.5%
- fesoterodine: 0.4% - 1.3%
- fexofenadine: postmarketing, 1.1% - 1.8%
- flecainide
- florbetapir: 0.4%
- fluconazole: postmarketing, uncommon
- fludrocortisone
- fludrocortisone acetate
- flumazenil
- flunisolide
- fluoxetine: frequent, very common, 1% - 33%
- flurbiprofen
- flutamide
- fluvastatin: postmarketing, common, 0.2% - 2.7%
- fluvoxamine: common, frequent, 4% - 35%
- fondaparinux: 0.917% - 5.41%
- formoterol: uncommon, 1.5%
- fosaprepitant
- fosaprepitant dimeglumine: 2.1% - 3.3%
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril: uncommon
- fosinoprilat
- fosphenytoin: infrequent
- frovatriptan: frequent
- gabapentin: postmarketing, infrequent, 1.1% - 7%
- gadobutrol
- gadoversetamide
- galantamine: 5%
- ganciclovir: 6% - 20%
- gatifloxacin
- gemcitabine: common
- gemifloxacin
- gliclazide: 1.1% - 2%
- glimepiride
- glipizide
- glutamine: 0% - 11.1%
- glycopyrrolate: common
- granisetron: common, 4.9% - 5%
- griseofulvin
- guanfacine: postmarketing, 0% - 12%
- haloperidol: very rare, postmarketing
- histamine
- hydrochlorothiazide
- hydrocodone
- hydromorphone: 2.91% - 6.51%
- hydroxybutyrate
- ibandronate: 0.8% - 3%
- ibuprofen
- iloprost: 8%
- imatinib: common, 0% - 19%
- imipramine
- imiquimod: postmarketing, uncommon, 0.2% - 0.4%
- indapamide
- indinavir: 0% - 3.1%
- indomethacin
- iodixanol
- iopromide
- ipratropium bromide: 0.2% - 1.9%
- irinotecan: 0% - 19%
- isomannide
- isopropyl unoprostone
- isoproterenol
- isosorbide-5-mononitrate
- isradipine
- itraconazole
- ixabepilone: 0% - 5%
- ketoconazole
- ketoprofen
- ketorolac
- ketorolac tromethamine: postmarketing
- ketotifen
- lacosamide: postmarketing
- lamivudine: 7%
- lamotrigine: 2% - 10%
- lanreotide
- lansoprazole
- lapatinib: very common, 0% - 6%
- leflunomide
- lenalidomide: common
- lercanidipine
- letrozole: uncommon, 0.078% - 7%
- leuprorelin acetate: 6% - 21.8%
- levetiracetam: 1.67% - 5%
- levodopa/carbidopa: 1.2%
- levonorgestrel
- levosimendan
- linezolid: 1.7% - 2.5%
- lisdexamfetamine dimesylate: postmarketing, 13% - 27%
- lisuride
- lomefloxacin
- loratadine
- lorcaserin: 3.52%
- losartan: 1.1%
- lovastatin: postmarketing
- loxapine
- lurasidone: 7% - 11%
- maprotiline: 2%
- maraviroc
- mebeverine
- meclofenamate: postmarketing
- medroxyprogesterone: 1%
- medroxyprogesterone acetate: 0.2 - 1.0%
- mefenamic acid
- mefloquine: postmarketing
- megestrol: 0% - 6%
- melatonin
- meloxicam: 0% - 3.6%
- memantine: 3.03%
- meperidine
- mephenytoin
- meropenem
- mesna: 5% - 11%
- metaproterenol: 1.8% - 9%
- methadone
- methamphetamine
- methocarbamol
- methotrexate
- methsuximide
- methylphenidate: postmarketing, very common, 0% - 17%
- methylprednisolone
- methylprednisolone sodium succinate
- methysergide
- metoclopramide: postmarketing
- metolazone
- metoprolol: postmarketing, rare, uncommon
- metronidazole
- midodrine
- mifepristone
- miglustat
- milnacipran: 12%
- mipomersen: 3%
- mirtazapine: postmarketing
- moclobemide
- modafinil: postmarketing, 4% - 6%
- mometasone furoate
- montelukast: postmarketing
- morphine
- moxifloxacin
- moxonidine: postmarketing
- mycophenolate mofetil: 2.1% - 52.3%
- mycophenolic acid: 23.5% - 52.3%
- nabilone: postmarketing
- nabumetone: 3%
- nadolol
- nalmefene
- naltrexone: postmarketing, 3%
- nandrolone
- naproxen: postmarketing
- nebivolol: 1%
- nefazodone: 1.5%
- nefopam
- nelarabine: 0% - 7%
- nelfinavir
- neostigmine
- niacin: postmarketing
- nicardipine
- nicorandil: uncommon
- nicotine
- nifedipine: 1.8%
- nilotinib: common
- nilutamide
- nisoldipine
- nitazoxanide
- nizatidine: 2.7%
- norethisterone
- norfloxacin
- nortriptyline
- ofatumumab: 0% - 10%
- ofloxacin
- olanzapine: postmarketing, 12% - 20%
- olmesartan: 0.189% - 1.59%
- olmesartan medoxomil
- olsalazine: 1%
- omeprazole: postmarketing, uncommon, common
- orlistat: uncommon
- oseltamivir: postmarketing
- oxaliplatin: 0% - 11%
- oxandrolone
- oxaprozin
- oxcarbazepine: 2% - 6%
- oxprenolol
- oxybutynin: 2.8% - 5.5%
- oxycodone: 5%
- oxymetholone
- oxymorphone: 4%
- paclitaxel: rare, common
- paliperidone
- palonosetron: 0.158% - 1.55%
- pamidronate: common, 0% - 25.1%
- pantoprazole: postmarketing, 1%
- parecoxib
- paricalcitol: 3% - 4.9%
- paroxetine: postmarketing, common, 1.3% - 20%
- pazopanib
- penbutolol: 1.9% - 2.6%
- pentamidine
- pentazocine
- pentosan polysulfate: 1%
- pentostatin
- pentoxifylline: 2.3%
- pergolide: frequent, 7.9%
- perhexiline
- perindopril: uncommon
- perphenazine
- phendimetrazine
- phenelzine
- phentermine
- phenylpropanolamine
- phenytoin: infrequent
- pilocarpine
- pimozide: postmarketing, 2%
- pindolol: 3% - 10%
- pioglitazone: uncommon
- piperacillin
- pirbuterol
- pirfenidone
- piroxicam
- pitavastatin: postmarketing
- pixantrone
- podophyllotoxin
- pomalidomide: 6.54% - 14.3%
- ponatinib: 0% - 12%
- posaconazole: 1.15% - 16.3%
- pramipexole: postmarketing, common, 4% - 27%
- pravastatin
- prazosin
- prednisolone
- prednisolone acetate
- prednisolone phosphate
- prednisone
- pregabalin: frequent, 3.8% - 10.7%
- procarbazine
- prochlorperazine
- progesterone
- promethazine
- propafenone: 0% - 2%
- propantheline
- propericiazine
- propofol
- propoxyphene napsylate
- propranolol: postmarketing
- prostacyclin
- protriptyline
- pyrantel
- quetiapine: 4.5% - 19.5%
- quinapril
- quinaprilat
- rabeprazole
- raloxifene: 5.5%
- raltegravir
- ramelteon: 0.3%
- ramipril
- ramiprilat
- ranitidine
- ranolazine
- rapamycin: 8% - 22%
- rasagiline: 4%
- reboxetine: 20.8%
- regadenoson: uncommon
- rescinnamine: 1.4%
- retinoic acid: postmarketing, 14%
- ribavirin: very common, 9% - 41%
- rifabutin: 1%
- rifapentine
- rifaximin: 7.14%
- rilpivirine: 3% - 4%
- riluzole: 2.1% - 3.5%
- rimantadine: 2.1% - 7%
- rimonabant
- risedronate: 1% - 2.3%
- risperidone: 0.3% - 32%
- ritonavir: 0.8% - 3.4%
- rivastigmine: infrequent, uncommon, 1% - 9%
- rizatriptan: infrequent
- rofecoxib
- roflumilast: 2.37%
- ropinirole
- ropivacaine: 2%
- rosuvastatin: postmarketing
- rotigotine: 5%
- rufinamide
- sacrosidase
- salbutamol: postmarketing, 0% - 6.1%
- salmeterol
- salmon calcitonin acetate
- saquinavir
- sertraline: very common, 1% - 28%
- sevoflurane
- sibutramine
- sildenafil: 4% - 7%
- silodosin
- simvastatin: 0.5% - 4%
- sitagliptin
- sitaxsentan: common, 2.01%
- sodium cromoglycate
- sofosbuvir: very common, 4% - 29%
- sotalol: 2.6% - 4.1%
- sparfloxacin: 1.9%
- spectinomycin
- stavudine: postmarketing
- stiripentol
- strontium ranelate: postmarketing
- sugammadex
- sulfadiazine
- sulfamethoxazole
- sulfasalazine
- sulindac
- sunitinib
- suvorexant
- tacrolimus: very common, 0% - 68%
- tadalafil: 4%
- tamoxifen: 9.08% - 9.99%
- tamsulosin: 1.42% - 2.4%
- tapentadol: 2% - 4%
- tegaserod: 1% - 2%
- telavancin: common
- telithromycin
- telmisartan: rare, uncommon, common
- temozolomide: common, 0% - 10.1%
- temsirolimus
- tenofovir: 3% - 18%
- tenofovir disoproxil fumarate: 3% - 18%
- terazosin
- terbutaline: 1.5%
- tesamorelin: 0% - 1.2%
- testosterone: postmarketing, 0% - 1.96%
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetrabenazine: 22%
- tetraen
- tetrahydrozoline
- thalidomide: 0% - 47.1%
- theophylline
- thiothixene
- thymidine: 2.58% - 3%
- thyroxine
- tiagabine: 3% - 6%
- tiaprofenic acid
- tigecycline: 2.3% - 3.3%
- timolol
- tinidazole
- tiotropium
- tipranavir: uncommon, 3.7%
- tofacitinib
- topiramate: very rare, postmarketing, 0% - 14%
- torasemide: 1.2%
- toremifene
- trabectedin
- tramadol: postmarketing, 0.926% - 10.9%
- tramazoline
- trametinib: 0% - 18%
- trandolapril
- trandolaprilat
- tranylcypromine
- trazodone: postmarketing, 6.4% - 9.9%
- treprostinil
- triamcinolone: postmarketing
- triamcinolone acetonide: postmarketing
- trifluoperazine
- trimethadione
- trimethoprim: very rare
- trimipramine
- trovafloxacin
- unoprostone
- v 1784: postmarketing, uncommon, 1% - 4%
- valdecoxib
- valganciclovir: 6.1% - 20%
- valproate: 9% - 15%
- valsartan: uncommon
- vandetanib: 13%
- vardenafil
- varenicline: 18% - 19%
- venlafaxine: postmarketing, common, 1% - 24%
- verapamil: postmarketing
- vigabatrin: 10% - 12%
- vilazodone: 6%
- vincristine: 32%
- vinflunine
- voriconazole: rare
- zafirlukast
- zalcitabine
- zaleplon: infrequent
- ziconotide: 6%
- zidovudine: rare, 5%
- zidovudine/lamivudine
- zileuton
- ziprasidone: postmarketing, 0% - 3%
- zoledronic acid: 10% - 13%
- zolmitriptan: infrequent
- zolpidem: postmarketing, rare, frequent
- zonisamide: 6%
- zopiclone: infrequent
- zuclopenthixol
|
Drugs with this indication
|
